Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
32.51
-0.70 (-2.11%)
Mar 31, 2025, 10:01 AM EDT - Market open
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$865,351
Profits / Employee
$203,928
Market Cap
5.29B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALKS News
- 4 days ago - New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder - PRNewsWire
- 4 weeks ago - Alkermes to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Alkermes' Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy Treatment - Seeking Alpha
- 6 weeks ago - Alkermes plc (ALKS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025 - PRNewsWire
- 7 weeks ago - Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025 - PRNewsWire
- 3 months ago - Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha